Molecular Diagnostics News and Research

RSS

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients.

9 Feb 2020

Prenatal single cell blood test for gene defects

With the current state of knowledge regarding genetic testing, non-invasive prenatal testing (NIPT) is in favor for genetic testing in unborn babies, using fragments of DNA circulating in the mother’s blood.

4 Feb 2020

Single-cell DNA assessment method can detect fetal genetic abnormalities

Non-invasive prenatal tests are used for fetal genetic disease screening in pregnant women. In contrast, invasive tests like amniocentesis carry the risk of causing fetal harm.

4 Feb 2020

Determining Microsatellite Instability Status Using Multiplex PCR-Based Methods

Determining microsatellite instability status using multiplex PCR-based methods used to screen for Lynch Syndrome, a dominant hereditary cancer propensity.

From Promega Corporation 24 Jan 2020

New technique accurately predicts which melanomas are likely to recur and spread

For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.

20 Jan 2020

Daily aspirin use may help prevent colorectal cancer

A new study has shown that regular use of aspirin may protect against heart disease, reduce colorectal tumor growth and prevent relapse.

7 Jan 2020

New blood test can help identify elderly concussion patients with brain tissue damage

Novel research shows that a blood test can differentiate elderly concussion patients with brain tissue damage from those without it. This finding, published in the special brain health collection of AACC's The Journal of Applied Laboratory Medicine, could help ensure that elderly patients with severe concussions receive crucial treatment for their injuries.

6 Jan 2020

AACC’s journal highlights new clinical tests that could improve care for concussions

In a special brain health collection, AACC's The Journal of Applied Laboratory Medicine highlights the innovative clinical tests that laboratory medicine experts are developing to improve care for concussions.

6 Jan 2020

Aspirin’s benefits may extend beyond heart health to colorectal cancer treatment

The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence of the disease.

6 Jan 2020

Detection of mouth, throat cancer through saliva testing could become reality

Cancer of the throat and mouth (oropharyngeal cancers, OPC) are common, and are increasing in incidence especially among younger people. However, these are difficult to diagnose as they are not seen either by the patient or during routine medical examinations.

15 Dec 2019

New technique may lead to earlier and easier detection of mouth and throat cancer

Unfortunately, cancers that occur in the back of the mouth and upper throat are often not diagnosed until they become advanced, partly because their location makes them difficult to see during routine clinical exams.

13 Dec 2019

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow.

From Thermo Fisher Scientific Inc. 9 Dec 2019

Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform

Tecan unveiled its new Cavro Magni Flex OEM robotic liquid handling instrument development platform at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo.

From Tecan 6 Dec 2019

Scientists are developing a new diagnostic tool for different types of breast cancers

Scientists are developing a new way to identify the unique chemical 'fingerprints' for different types of breast cancers.

2 Dec 2019

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the fully-automated BD MAX System.

From BD (Becton, Dickinson and Company) 30 Oct 2019

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Sense Biodetection Limited has today announced that it has raised £12.3m to develop its portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product.

29 Oct 2019

Researchers discover how the body repairs damaged DNA

Researchers from the University of Copenhagen have made an extraordinary discovery in how the body repairs damaged DNA, which can lead to better understanding and management of diseases such as cancer.

25 Oct 2019

Using machine learning on ultrasound images to predict risk of thyroid cancer

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of thyroid nodules are not cancerous and cause no symptoms.

24 Oct 2019

Leading experts to discuss about emergence and growing use of point-of-care testing

Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing.

2 Oct 2019

AMP announces recipients of 2019's Award for Excellence in Molecular Diagnostics

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year's Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

19 Sep 2019

Molecular Diagnostics News and Research

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

Prenatal single cell blood test for gene defects

Single-cell DNA assessment method can detect fetal genetic abnormalities

Determining Microsatellite Instability Status Using Multiplex PCR-Based Methods

New technique accurately predicts which melanomas are likely to recur and spread

Daily aspirin use may help prevent colorectal cancer

New blood test can help identify elderly concussion patients with brain tissue damage

AACC’s journal highlights new clinical tests that could improve care for concussions

Aspirin’s benefits may extend beyond heart health to colorectal cancer treatment

Detection of mouth, throat cancer through saliva testing could become reality

New technique may lead to earlier and easier detection of mouth and throat cancer

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Tecan unveils Cavro Magni Flex OEM robotic liquid handling instrument development platform

Scientists are developing a new diagnostic tool for different types of breast cancers

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Researchers discover how the body repairs damaged DNA

Using machine learning on ultrasound images to predict risk of thyroid cancer

Leading experts to discuss about emergence and growing use of point-of-care testing

AMP announces recipients of 2019's Award for Excellence in Molecular Diagnostics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News